Скачать с ютуб tPBM May Reduce Symptoms of Autism - Eugenia Steinhold PhD, JelikaLite Corp. @Synchrony2021 в хорошем качестве

tPBM May Reduce Symptoms of Autism - Eugenia Steinhold PhD, JelikaLite Corp. @Synchrony2021

Transcranial Photobiomodulation (tPBM) May Reduce Symptoms of Autism, as measured by Behavioral Change and EEG - a presentation by Eugenia Steingold, PhD, a pediatric psychologist, who has been working with children on the Autism Spectrum for the last 15 years. She completed her doctoral studies in Cognitive Psychology at Princeton University, followed by postdoctoral fellowship in the Laboratory for Developmental Studies at Harvard University. Her original research focused on Language Acquisition and Processing. Her research projects have been sponsored by NIH and NSF.  Her current research and clinical interests include Autism, Language Delays, Developmental Delays, Cognition, and neurological and psychological response to trauma. During the last two years, as a CSO of Jelikalite, she has been working on developing and validating tPBM technology for treating Autism in young children. 🎥 This talk was part of Synchrony 2021 Online Symposium - 'From Bench to Biopharma', organised by the The BRAIN Foundation in partnership with UC Davis MIND Institute and CalTech. 🎥 For more Synchrony 2021 talks and highlights:    • Synchrony Symposium 2021 - From Bench...   🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 Synchrony https://synchronysymposium.com/ is the first and only international symposium on translational research in #autism, that brings together academia, #biotech, pharmaceutical companies and #venture partners from around the world with the mission to improve health and quality of life of people with #autismspectrumdisorder. 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 The BRAIN Foundation https://brainfoundation.org/ is a 501c(3) non-profit. The founders of BRAIN envision a world where every child and adult on the autism spectrum is healthy, participates fully in education and employment, and has a better quality of life. It aims to catalyze research that results in evidence-based interventions for the disabilities associated with autism, and also results in better medical standard of care. To accomplish this, it funds impactful research through #philanthropy and our network of partners in the venture, corporate, and grassroots community.